Malin invests a further €34.5m in Altan Pharma

Malin, the life sciences- focused investment vehicle, run by former Elan executives, has announced a €34.5m investment in Altan Pharma, its second major investment in as many days.

Malin invests a further €34.5m in Altan Pharma

Earlier this week, Malin — which recently raised €330m from its IPO on the secondary market of the Irish Stock Exchange — announced a $35m (€31m) initial investment in US drug development firm, Melinta Therapeutics, with the commitment in place for a further $10m investment over the coming 12 months.

While the Melinta deal sees Malin take an initial minority stake in the firm, yesterday’s Altan announcement covers a controlling 65% shareholding.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited